drugset / Trial / NCT02471859
A Safety, Tolerability, and Pharmacokinetic Study of GDC-3280 in Healthy Participants
RandomizedParallel-groupDouble-blindBasic science
Summary
This is a Phase 1, Randomized, Double-Blind, Placebo-Controlled, Ascending, Single- and Multiple-Oral Dose, Safety, Tolerability, and Pharmacokinetic Study of GDC-3280 in Healthy Subjects.
Timeline
- Start
- 2015-06
- Primary completion
- 2015-12
- Completion
- 2015-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | GDC-3280 | Unknown | — | Oral |
Indications
No indication recorded.